France is making significant progress in its efforts to establish a regulated medical cannabis framework. On March 19, 2025, French officials submitted three documents to the European Union for approval, each outlining key aspects of the proposed medical cannabis legalization process.
The three decrees, which had been finalized earlier, were initially scheduled to be sent to the EU in June or July of the previous year. However, the collapse of the French government and resulting political instability caused delays in the legislative process. The first decree defines the framework for regulating cannabis-based medicines, while the other two detail the technical specifications, real-world conditions, and enforceable standards for what could become one of Europe’s largest medical cannabis markets.
A crucial part of this initiative is that cannabis will be considered a treatment of last resort. Patients will need to demonstrate that they have either failed to respond to or are intolerant of all standard therapies before accessing cannabis treatments. This approach aligns with France’s previous experimental programs for medical cannabis.
English 
Spanish 
German 
Czech